-

Fitch Affirms Sabra’s Credit Rating and Outlook

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Fitch Ratings has affirmed the ratings for Sabra and its subsidiaries at 'BBB-'; Fitch’s Rating Outlook of Negative also remains unchanged.

The report notes Sabra's portfolio quality and diversification, strong liquidity and no near-term maturities as key drivers for its ratings decisions. Fitch also views Sabra’s recent decision to reduce its upcoming quarterly dividend expected to be declared in May 2020 to $0.30 from $0.45 positively because of the additional liquidity it will provide that is expected to be used to manage leverage and fund operations. The full report can be found on its website at www.fitchratings.com.

Commenting on the Fitch report, Rick Matros, CEO and Chairman, said, “We are pleased with the improvements we have made to our balance sheet over the last year and will continue to put a high priority on a healthy balance sheet and our ratings.”

ABOUT SABRA

Sabra Health Care REIT, Inc. (Nasdaq: SBRA), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

Contacts

Investor & Media Inquiries:
1-888-393-8248 or investorinquiries@sabrahealth.com

Sabra Health Care REIT, Inc.

NASDAQ:SBRA

Release Versions

Contacts

Investor & Media Inquiries:
1-888-393-8248 or investorinquiries@sabrahealth.com

More News From Sabra Health Care REIT, Inc.

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. SECOND QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2026 were as follows: Net Loss: $(0.10) FFO: $(0.02) Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.40 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.49x Senior Housing - Leased: 1.52x B...

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.The report highlights how Sabra is scaling successful pilot technologies into portfolio-wide initiatives, expanding solutions that improve care delivery and continuing to invest in resilient, efficient operations. Together with the Company's broader sustainability efforts, these initiatives reflect Sabra’s continued int...

Sabra Issues Business Update and Increases Full-Year 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere (“Avamere”). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare (“Cascadia”), a leading diversified healthcare operator concentrated in the Pacific Northwest with approxi...
Back to Newsroom